| Literature DB >> 9468088 |
P B Duell1, W E Connor, D R Illingworth.
Abstract
The findings in this case indicate that atorvastatin, like other DL-3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, may increase the risk of myositis and rhabdomyolysis when used in combination with gemfibrozil.Entities:
Mesh：
Substances：
Year: 1998 PMID： 9468088 DOI： 10.1016/s0002-9149(97)00907-7
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778